CIK 0001070494 · Large accelerated filer
ACADIA PHARMACEUTICALS INC
Sign in to watch- Ticker
- ACAD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 061376651
- Phone
- 858-558-2871
- Business address
- 12830 EL CAMINO REAL, SUITE 400, SAN DIEGO, CA, 92130
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $69,342
- in 1 filing
Net −$69,342. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-04-29 | KIM AUSTIN D. EVP,General Counsel, Secretary | Option exercise · Restricted Stock Units | −3,005 | 3,005 | ||
| 2022-04-29 | Teehan Brendan EVP, COO, Head of Commercial | Option exercise | +1,567 | 3,989 | ||
| 2022-04-29 | Teehan Brendan EVP, COO, Head of Commercial | Option exercise · Restricted Stock Units | −1,567 | 1,567 | ||
| 2022-04-08 | Kihara James Principal Accounting Officer | Sale | −1,025 | $27.05 | $28K | 2,433 |
| 2022-04-07 | Kihara James Principal Accounting Officer | Option exercise | +2,977 | 3,458 | ||
| 2022-04-07 | Kihara James Principal Accounting Officer | Option exercise · Restricted Stock Units | −2,977 | 2,978 | ||
| 2022-04-05 | Kihara James Principal Accounting Officer | Grant or award · Stock Options (Right to Buy) | +13,793 | 13,793 | ||
| 2022-04-05 | Kihara James Principal Accounting Officer | Grant or award · Restricted Stock Units | +8,039 | 8,039 | ||
| 2022-04-05 | Teehan Brendan EVP, COO, Head of Commercial | Grant or award · Stock Options (Right to Buy) | +68,966 | 68,966 | ||
| 2022-04-05 | Teehan Brendan EVP, COO, Head of Commercial | Grant or award · Restricted Stock Units | +20,096 | 20,096 | ||
| 2022-04-05 | Schneyer Mark C. EVP, Chief Financial Officer | Grant or award · Stock Options (Right to Buy) | +72,414 | 72,414 | ||
| 2022-04-05 | Schneyer Mark C. EVP, Chief Financial Officer | Grant or award · Restricted Stock Units | +21,101 | 21,101 | ||
| 2022-04-05 | KIM AUSTIN D. EVP,General Counsel, Secretary | Grant or award · Stock Options (Right to Buy) | +65,517 | 65,517 | ||
| 2022-04-05 | KIM AUSTIN D. EVP,General Counsel, Secretary | Grant or award · Restricted Stock Units | +19,092 | 19,092 | ||
| 2022-04-05 | KIM AUSTIN D. EVP,General Counsel, Secretary | Grant or award · Restricted Stock Units | +96,463 | 96,463 | ||
| 2022-04-05 | Stankovic Srdjan R. President | Grant or award · Stock Options (Right to Buy) | +124,138 | 124,138 | ||
| 2022-04-05 | Stankovic Srdjan R. President | Grant or award · Restricted Stock Units | +36,174 | 36,174 | ||
| 2022-04-05 | Stankovic Srdjan R. President | Grant or award · Restricted Stock Units | +144,695 | 144,695 | ||
| 2022-04-05 | DAVIS STEPHEN CEO | Grant or award · Stock Options (Right to Buy) | +237,931 | 237,931 | ||
| 2022-04-05 | DAVIS STEPHEN CEO | Grant or award · Restricted Stock Units | +69,333 | 69,333 |
Page 27 of 63 · 1,260 trades